Hye Bin Gwag1, June Soo Kim2, Kyoung-Min Park2, Young Keun On2, Seung-Jung Park3. 1. Division of Cardiology, Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea. 2. Division of Cardiology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. 3. Division of Cardiology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. orthovics@gmail.com.
Abstract
BACKGROUND: It has been known that ventricular conduction delays play a key role in the cardiac resynchronization therapy (CRT) response of patients with advanced heart failure (HF). However, no study to our knowledge has yet evaluated the serial changes in conduction times measured between different electrodes of CRT devices. METHODS AND RESULTS: The Reduction or Extension of Conduction Time with Ventricular Electromechanical Remodeling (RECOVER) study (NCT04397224) was designed to investigate serial changes in interelectrode conduction times and to elucidate their prognostic value. We plan to enroll 100 patients implanted with CRT systems with endocardial quadripolar left ventricular leads. Patients will be scheduled for follow-up every 3 months over a period of 2 years, where they will undergo measurement of interelectrode conduction times to evaluate their serial changes. The primary outcome of the RECOVER study is the correlation between the degree of conduction time changes and the CRT response as defined by echocardiography. The time course and prognostic value of the serial changes in conduction times will be investigated as well. CONCLUSION: The RECOVER study is investigating whether serial changes in interelectrode conduction times can be useful parameters in predicting the CRT response or detecting worsening HF at an early stage.
BACKGROUND: It has been known that ventricular conduction delays play a key role in the cardiac resynchronization therapy (CRT) response of patients with advanced heart failure (HF). However, no study to our knowledge has yet evaluated the serial changes in conduction times measured between different electrodes of CRT devices. METHODS AND RESULTS: The Reduction or Extension of Conduction Time with Ventricular Electromechanical Remodeling (RECOVER) study (NCT04397224) was designed to investigate serial changes in interelectrode conduction times and to elucidate their prognostic value. We plan to enroll 100 patients implanted with CRT systems with endocardial quadripolar left ventricular leads. Patients will be scheduled for follow-up every 3 months over a period of 2 years, where they will undergo measurement of interelectrode conduction times to evaluate their serial changes. The primary outcome of the RECOVER study is the correlation between the degree of conduction time changes and the CRT response as defined by echocardiography. The time course and prognostic value of the serial changes in conduction times will be investigated as well. CONCLUSION: The RECOVER study is investigating whether serial changes in interelectrode conduction times can be useful parameters in predicting the CRT response or detecting worsening HF at an early stage.
Authors: John Rickard; Alan Cheng; David Spragg; Daniel Cantillon; Mina K Chung; W H Wilson Tang; Bruce L Wilkoff; Niraj Varma Journal: Heart Rhythm Date: 2012-09-18 Impact factor: 6.343
Authors: Giuseppe Boriani; Sean Connors; Zbigniew Kalarus; Bernd Lemke; Wilfried Mullens; Joaquin Osca Asensi; Pekka Raatikainen; Carlo Gazzola; Taraneh G Farazi; Christophe Leclercq Journal: JACC Clin Electrophysiol Date: 2015-11-11
Authors: Renaud Gervais; Christophe Leclercq; Aparna Shankar; Sandra Jacobs; Hans Eiskjaer; Arne Johannessen; Nick Freemantle; John G F Cleland; Luigi Tavazzi; Claude Daubert Journal: Eur J Heart Fail Date: 2009-06-07 Impact factor: 15.534
Authors: Hye Bin Gwag; Youngjun Park; Seong Soo Lee; June Soo Kim; Kyoung Min Park; Young Keun On; Seung Jung Park Journal: J Korean Med Sci Date: 2019-07-15 Impact factor: 2.153